Experiment 69155
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Rheum species (POLYGONACEAE) |
| Citation | MANTANI,N: SEKIYA,N: SAKAI,S: KOGURE,T: SHIMADA,Y: TERASAWA,K:. (2002). RHUBARB USE IN PATIENTS TREATED WITH KAMPO MEDICINES- A RISK FOR GASTRIC CANCER?. 122(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE PRESENT STUDY ASSESSED PATIENTS DIAGNOSED WITH GASTRIC CANCER DURING THE PERIOD BETWEEN 1979 AND 1999, WHO HAD BEEN ADMINISTERED RHUBARB BEFORE THE DEVELOPMENT OF GASTRIC CANCER. AMONG THE 10 ENROLLED PATIENTS, ONLY 2 PATIENTS HAD BEEN ADMINISTERED RHUBARB BEFORE THE DEVELOPMENT OF GASTRIC CARCINOMA. THE OTHER 8 PATIENTS HAD NEVER RECEIVED RHUBARB BEFORE THE DEVELOPMENT OF GASTRIC CARCINOMA. RHUBARB USE MAY HAVE LITTLE CONNECTION WITH THE DEVELOPMENT OF GASTRIC CANCER IN PRACTICE, EVEN IF SOME INGREDIENTS IN RHUBARB HAVE SHOWN CARCINOGENIC ACTIVITY IN EXPERIMENTAL STUDIES. |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |
| Gender | GIVEN TO BOTH SEXES |